Profound Medical Corp (PRN) — Cash Flow-to-Debt Ratio
Profound Medical Corp (PRN) has a Cash Flow-to-Debt Ratio of -0.60x as of March 2026, meaning its operating cash flow of CA$-11.77 Million could theoretically repay -1% of its total liabilities (CA$19.58 Million) in one year. Explore Profound Medical Corp cash flow conversion to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Profound Medical Corp Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Profound Medical Corp across 12 annual periods. Also explore Profound Medical Corp assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Profound Medical Corp (2014–2025)
Year-by-year debt coverage analysis for Profound Medical Corp. For market capitalisation and broader financial context, see Profound Medical Corp market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | CA$-53.39 Million | CA$102.04 Million | ▲ +78.1% |
| 2024 | -2.39x | CA$-23.45 Million | CA$9.81 Million | ▼ -34.6% |
| 2023 | -1.78x | CA$-22.61 Million | CA$12.73 Million | ▲ +14.5% |
| 2022 | -2.08x | CA$-25.80 Million | CA$12.42 Million | ▲ +42.8% |
| 2021 | -3.63x | CA$-22.36 Million | CA$6.16 Million | ▼ -28.0% |
| 2020 | -2.84x | CA$-20.57 Million | CA$7.25 Million | ▼ -188.7% |
| 2019 | -0.98x | CA$-15.33 Million | CA$15.60 Million | ▼ -7.0% |
| 2018 | -0.92x | CA$-13.43 Million | CA$14.63 Million | ▲ +15.1% |
| 2017 | -1.08x | CA$-11.81 Million | CA$10.93 Million | ▲ +34.0% |
| 2016 | -1.64x | CA$-10.79 Million | CA$6.59 Million | ▼ -72.5% |
| 2015 | -0.95x | CA$-4.94 Million | CA$5.21 Million | ▲ +96.6% |
| 2014 | -28.03x | CA$-2.88 Million | CA$102.73K | — |